Literature DB >> 30913536

MECHANISMS OF ENDOCRINE DISEASE: Sarcopenia in endocrine and non-endocrine disorders.

Victoria Zeghbi Cochenski Borba1, Tatiana Lemos Costa1, Carolina Aguiar Moreira1,2, Cesar Luiz Boguszewski1.   

Abstract

Objective This paper reviews the main mechanisms, diagnostic criteria, treatment options and available data on sarcopenia in endocrine and non-endocrine disorders. The literature notes the presence of sarcopenia as a comorbid condition or a complication of another clinical situation and not a disease that only affects elderly patients. Method We performed a literature review, focusing on the following: mechanisms related to sarcopenia in elderly patients, and sarcopenia as it presents in the context of chronic and endocrine diseases; diagnostic tools and methods; aspects of sarcopenia and treatment options specific to chronic diseases and endocrine disorders respectively. Results Sarcopenia in chronic and endocrine disorders shares many mechanisms with sarcopenia affecting elderly patients, but certain diseases can have a predominant aspect that leads to sarcopenia. The prevalence of sarcopenia varies, depending on different diagnostic criteria, from around 12 to 60% in chronic illnesses and 15 to 90% in endocrine disorders. The interplay between sarcopenia, chronic diseases and elderly patients requires further study, to clarify the impact of each, in terms of prognosis and mortality. Conclusion Awareness of the presentation of sarcopenia in the context of other diseases and ages (and not just the elderly) is fundamental to ensure that preventive measures can be deployed.

Entities:  

Mesh:

Year:  2019        PMID: 30913536     DOI: 10.1530/EJE-18-0937

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  3 in total

1.  Fatty Liver Index and Skeletal Muscle Density.

Authors:  Julie A Pasco; Sophia X Sui; Emma C West; Kara B Anderson; Pamela Rufus-Membere; Monica C Tembo; Natalie K Hyde; Lana J Williams; Zoe S J Liu; Mark A Kotowicz
Journal:  Calcif Tissue Int       Date:  2022-01-13       Impact factor: 4.000

2.  Prdx6 Plays a Main Role in the Crosstalk Between Aging and Metabolic Sarcopenia.

Authors:  Francesca Pacifici; David Della-Morte; Francesca Piermarini; Roberto Arriga; Maria Giovanna Scioli; Barbara Capuani; Donatella Pastore; Andrea Coppola; Silvia Rea; Giulia Donadel; Aikaterini Andreadi; Pasquale Abete; Giuseppe Sconocchia; Alfonso Bellia; Augusto Orlandi; Davide Lauro
Journal:  Antioxidants (Basel)       Date:  2020-04-17

3.  DXA-Derived Indices in the Characterisation of Sarcopenia.

Authors:  Natascha Schweighofer; Caterina Colantonio; Christoph W Haudum; Barbara Hutz; Ewald Kolesnik; Ines Mursic; Stefan Pilz; Albrecht Schmidt; Vanessa Stadlbauer; Andreas Zirlik; Thomas R Pieber; Nicolas Verheyen; Barbara Obermayer-Pietsch
Journal:  Nutrients       Date:  2021-12-31       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.